References
- Andrews, J.M. 2009. BSAC standardized disc susceptibility testing method (version 8). J. Antimicrob. Chemother. 64, 454-489. https://doi.org/10.1093/jac/dkp244
- Antonio, M., McFerran, N., and Pallen, M.J. 2002. Mutations affecting the Rossman fold of isoleucyl-tRNA synthetase are correlated with low-level mupirocin resistance in Staphylococcus aureus. Antimicrob. Agents Chemother. 46, 438-442. https://doi.org/10.1128/AAC.46.2.438-442.2002
- Bastos, M.C.F., Mondino, P.J.J., Azevedo, M.L.B., Santos, K.R.N., and Giambiagi-deMarval, M. 1999. Molecular characterization and transfer among Staphylococcus strains of a plasmid conferring high-level resistance to mupirocin. Eur. J. Clin. Microbiol. Infect. Dis. 18, 393-398. https://doi.org/10.1007/s100960050306
- Caierao, J., Berquo, L., Dias, C., and d'Azevedo, P.A. 2006. Decrease in the incidence of mupirocin resistance among methicillin-resistant Staphylococcus aureus in carriers from an intensive care unit. Am. J. Infect. Control 34, 6-9. https://doi.org/10.1016/j.ajic.2005.08.006
- Clinical and Laboratory Standards Institute. 2006. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. M7-A7. CLSI, Wayne, Pa, USA.
- Clinical and Laboratory Standards Institute. 2009. Performance standards for antimicrobial susceptibility testing. M100-S19. CLSI. Wayne, Pa, USA.
- Creagh, S. and Lucey, B. 2007. Interpretive criteria for mupirocin susceptibility testing of Staphylococcus spp. using CLSI guidelines. Br. J. Biomed. Sci. 64, 1-5. https://doi.org/10.1080/09674845.2007.11732746
- Dyke, K.G., Aubert, S., and el Solh, N. 1992. Multiple copies of IS256 in staphylococci. Plasmid 28, 235-246. https://doi.org/10.1016/0147-619X(92)90055-F
- Emsley, P. and Cowtan, K. 2004. Coot: model-building tools for molecular graphics. Acta Crystallogr. D. Biol. Crystallogr. 60, 2126-2132. https://doi.org/10.1107/S0907444904019158
- Fujimura, S., Tokue, Y., and Watanabe, A. 2003. Isoleucyl-tRNA synthetase mutations in Staphylococcus aureus clinical isolates and in vitro selection of low-level mupirocin-resistant strains. Antimicrob. Agents Chemother. 47, 3373-3374. https://doi.org/10.1128/AAC.47.10.3373-3374.2003
- Gilbart, J., Perry, C.R., and Slocombe, B. 1993. High-level mupirocin resistance in Staphylococcus aureus: evidence for two distinct isoleucyl-tRNA synthetases. Antimicrob. Agents Chemother. 37, 32-38. https://doi.org/10.1128/AAC.37.1.32
- Hodgson, J.E., Curnock, S.P., Dyke, K.G., Morris, R., Sylvester, D.R., and Gross, M.S. 1994. Molecular characterization of the gene encoding high-level mupirocin resistance in Staphylococcus aureus J2870. Antimicrob. Agents Chemother. 38, 1205-1208. https://doi.org/10.1128/AAC.38.5.1205
- Hurdle, J.G., O'Neill, A.J., Mody, L., Chopra, I., and Bradley, S.F. 2005. In vivo transfer of high-level mupirocin resistance from Staphylococcus epidermidis to methicillin-resistant Staphylococcus aureus associated with failure of mupirocin prophylaxis. J. Antimicrob. Chemother. 56, 1166-1168. https://doi.org/10.1093/jac/dki387
- Kim, S.M., Lee, D.C., Park, S.D., Kim, B.S., Kim, J.K., Choi, M.R., Park, S.Y., Hwang, S.M., Shin, N.Y., Shim, E.S., and et al. 2009. Genotype, coagulase type and antimicrobial susceptibility of methicillinresistant Staphylococcus aureus isolated from dermatology patients and healthy individuals in Korea. J. Bacteriol. Virol. 39, 307-316. https://doi.org/10.4167/jbv.2009.39.4.307
- Kim, S.M., Park, S.Y., and Park, S.D. 2011. Isolation and antimicrobial susceptibility of mupirocin-resistant and methicillin-resistant Staphylococcus aureus from clinical samples. J. Bacteriol. Virol. 41, 279-286. https://doi.org/10.4167/jbv.2011.41.4.279
- Kresken, M., Hafner, D., Schmitz, F.J., and Wichelhaus, T.A. 2004. Prevalence of mupirocin resistance in clinical isolates of Staphylococcus aureus and Staphylococcus epidermidis: results of the Antimicrobial Resistance Surveillance Study of the Paul-Ehrlich-Society for Chemotherapy, 2001. Int. J. Antimicrob. Agents 23, 577-581. https://doi.org/10.1016/j.ijantimicag.2003.11.007
- Lee, A.S., Macedo-Vinas, M., Francois, P., Renzi, G., Vernaz, N., Schrenzel, J., Pittet, D., and Harbarth, S. 2011a. Trends in mupirocin resistance in meticillin-resistant Staphylococcus aureus and mupirocin consumption at a tertiary care hospital. J. Hosp. Infect. 77, 360-362. https://doi.org/10.1016/j.jhin.2010.11.002
- Lee, A.J., Suh, H.S., Jeon, C.H., and Kim, S.G. 2011b. Prevalence and clinical characteristics of mupirocin-resistant Staphylococcus aureus. Korean J. Clin. Microbiol. 14, 18-23. https://doi.org/10.5145/KJCM.2011.14.1.18
- Lee, H.J., Suh, J.T., Kim, Y.S., Lenz, W., Bierbaum, G., and Schaal, K.P. 2001. Typing and antimicrobial susceptibilities of methicillin resistant Staphylococcus aureus (MRSA) strains isolated in a hospital in Korea. J. Kor. Med. Sci. 16, 381-385. https://doi.org/10.3346/jkms.2001.16.4.381
- Leyden, J.J. 1990. Mupirocin: a new topical antibiotic. J. Am. Acad. Dermatol. 22, 879-883. https://doi.org/10.1016/0190-9622(90)70117-Z
- Lim, K.T., Hanifah, Y.A., Yusof, M.Y.M., and Thong, K.L. 2010. Prevalence of mupirocin resistance in methicillin-resistant Staphylococcus aureus strains isolated from a Malaysian hospital. Jpn. J. Infect. Dis. 63, 286-289.
- Long, B.H. 2008. Fusidic acid in skin and soft-tissue infections. Acta Derm. Venereol. 88, Supplement 216, 14-20. https://doi.org/10.2340/00015555-0387
- Morton, T.M., Johnston, J.L., Patterson, J., and Archer, G.L. 1995. Characterization of a conjugative staphylococcal mupirocin resistance plasmid. Antimicrob. Agents Chemother. 39, 1272-1280. https://doi.org/10.1128/AAC.39.6.1272
- Oommen, S.K., Appalaraju, B., and Jinsha, K. 2010. Mupirocin resistance in clinical isolates of staphylococci in a tertiary care centre in south India. Indian. J. Med. Microbiol. 28, 372-375.
- O'Shea, S., Cotter, L., Creagh, S., Lydon, S., and Lucey, B. 2009. Mupirocin resistance among staphylococci: trends in the southern region of Ireland. J. Antimicrob. Chemother. 64, 649-669. https://doi.org/10.1093/jac/dkp227
- Park, S.Y., Kim, S.M., and Park, S.D. 2012. The prevalence, genotype and antimicrobial susceptibility of high- and low-level mupirocin resistant methicillin-resistant Staphylococcus aureus. Ann. Dermatol. 24, 32-38. https://doi.org/10.5021/ad.2012.24.1.32
- Petinaki, E., Spiliopoulou, I., Kontos, F., Maniati, M., Bersos, Z., Stakias, N., Malamou-Lada, H., Koutsia-Carouzou, C., and Maniatis, A.N. 2004. Clonal dissemination of mupirocin-resistant staphylococci in Greek hospitals. J. Antimicrob. Chemother. 53, 105-108.
- Schmitz, F.J., Lindenlauf, E., Hofmann, B., Fluit, A.C., Verhoef, J., Heinz, H.P., and Jones, M.E. 1998. The prevalence of low- and high-level mupirocin resistance in staphylococci from 19 European hospitals. J. Antimicrob. Chemother. 42, 489-495. https://doi.org/10.1093/jac/42.4.489
-
Silvian, L.F., Wang, J., and Steitz, T.A. 1999. Insights into editing from an Ile-tRNA synthetase structure with
$tRNA^{ile}$ and mupirocin. Science 285, 1074-1077. https://doi.org/10.1126/science.285.5430.1074 - Sutherland, R., Boon, R.J., Griffin, K.E., Masters, P.J., Slocombe, B., and White, A.R. 1985. Antibacterial activity of mupirocin (pseudomonic acid), a new antibiotic for topical use. Antimicrob. Agents Chemother. 27, 495-498. https://doi.org/10.1128/AAC.27.4.495
- Thomas, D.G., Wilson, J.M., Day, M.J., and Russell, A.D. 1999. Mupirocin resistance in staphylococci: development and transfer of isoleucyl tRNA synthetase-mediated resistance in vitro. J. Appl. Microbiol. 86, 715-722. https://doi.org/10.1046/j.1365-2672.1999.00718.x
- Udo, E.E., Jacob, L.E., and Mathew, B. 2001. Genetic analysis of methicillin-resistant Staphylococcus aureus expressing high- and low-level mupirocin reistance. J. Med. Microbiol. 50, 909-915. https://doi.org/10.1099/0022-1317-50-10-909
- Vaara, M. 1992. The outer membrane as the penetration barrier against mupirocin in Gram-negative enteric bacteria. J. Antimicrob. Chemother. 29, 221-222. https://doi.org/10.1093/jac/29.2.221
- Vasquez, J.E., Walker, E.S., Franzus, B.W., Overbay, B.K., Reagan, D.R., and Sarubbi, F.A. 2000. The epidemiology of mupirocin resistance among methicillin-resistant Staphylococcus aureus at a Veterans' Affairs hospital. Infect. Control Hosp. Epidemiol. 21, 459-464. https://doi.org/10.1086/501788
- Vivoni, A.M., Santos, K.R.N., de-Oliveira, M.P., Giambiagi-deMarval, M., Ferreira, A.L.P., Riley, L.W., and Moreira, B.M. 2005. Mupirocin for controlling methicillin resistant Staphylococcus aureus: lessons from a decade of use at a university hospital. Infect. Control Hosp. Epidemiol. 26, 662-667. https://doi.org/10.1086/502599
- Yang, J.A., Park, D.W., Sohn, J.W., Yang, I.S., Kim, K.H., and Kim, M.J. 2006. Molecular analysis of isoleucyl-tRNA synthetase mutations in clinical isolates of methicillin-resistant Staphylococcus aureus with low-level mupirocin resistance. J. Korean Med. Sci. 21, 827-832. https://doi.org/10.3346/jkms.2006.21.5.827
- Yanagisawa, T., Lee, J.T., Wu, H.C., and Kawakami, M. 1994. Relationship of protein structure of isoleucyl-tRNA synthetase with pseudomonic acid resistance of Escherichia coli. A proposed mode of action of pseudomonic acid as an inhibitor of isoleucyl-tRNA synthetase. J. Biol. Chem. 269, 24304-24309.
- Yoo, J.I., Shin, E.S., Cha, J.O., Lee, J.K., Jung, Y.H., Lee, K.M., Kim, B.S., and Lee, Y.S. 2006. Clonal dissemination and mupA gene polymorphism of mupirocin-resistant Staphylococcus aureus isolates from long-term-care facilities in South Korea. Antimicrob. Agents Chemother. 50, 365-367. https://doi.org/10.1128/AAC.50.1.365-367.2006
- Yoo, J.I., Shin, E.S., Chung, G.T., Lee, K.M., Yoo, J.S., and Lee, Y.S. 2010. Restriction fragment length polymorphism (RFLP) patterns and sequence analysis of high-level mupirocin-resistant methicillin-resistant staphylococci. Int. J. Antimicrob. Agents 35, 50-55. https://doi.org/10.1016/j.ijantimicag.2009.08.017
- Yun, H.J., Lee, S.W., Yoon, G.M., Kim, S.Y., Choi, S., Lee, Y.S., Choi, E.C., and Kim, S. 2003. Prevalence and mechanisms of low- and high-level mupirocin resistance in staphylococci isolated from a Korean hospital. J. Antimicrob. Chemother. 51, 619-623. https://doi.org/10.1093/jac/dkg140
Cited by
- Characteristics of Coagulase-negative Staphylococci Isolates from Dental Clinic Environments in Busan, Korea vol.26, pp.2, 2016, https://doi.org/10.5352/JLS.2016.26.2.220